Mediation between Bayer and plaintiffs in the United States aims to clarify all justified claims related to Roundup herbicide both at the national and state level, mediator Ken Feinberg told a German magazine.
“The mediation is going slowly but steadily,” Wirtschaftswoche on Wednesday quoted Feinberg as saying.
Bayer is trying to reach a settlement after earlier court rulings against it. The German drugs and pesticides maker, which acquired Roundup and other glyphosate-based weed killers as part of its $63 billion takeover of Monsanto last year, faces potentially heavy litigation costs as plaintiffs claim Roundup causes cancer, something Bayer disputes.
(Reporting by Riham Alkousaa Editing by Michelle Martin)
Topics Claims
Was this article valuable?
Here are more articles you may enjoy.
Brown & Brown Estimates Cost of Howden-Driven Talent War Could Hit $60M in 2026 
Company at Center of Cyclospora Outbreak Complained to White House, Source Says 
After 55 Years in Florida Insurance, Tom Lynch Reflects on Agencies, Changes Needed 
Cost of a Data Breach Reaches Record $5 Million on Average 
